Chairpersons :

Avinash Deo, Vivek Agarwala, Amul Kapoor

Reviewer :

Adwaita Gore

1. Adjuvant pertuzumab and trastuzumab in early HER2-positive breast cancer

Author: Gunter Von Minckwitz

Citation: N Engl J Med 2017; 377:122-131

2. Neratinib after Trastuzumab (T)-based adjuvant therapy in early-stage HER2+ Breast

Cancer (BC): 5-year analysis of the phase III ExteNET trial

Author: Miguel Martin Jimenez

Citation: Annals of Oncology (2017) 28 (suppl_5): v43-v67.ESMO Abstract 149O